Clinical Trial: A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07380334) titled 'A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors' on Jan. 15.

Brief Summary: This study is a multicenter, open label, dose exploration/efficacy extension Phase I clinical trial aimed at evaluating the safety, tolerability, pharmacokinetics and efficacy of SHR-1049 injection in patients with advanced solid tumors.

Study Start Date: Jan. 21

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: DRUG: SHR-1049 Injection

SHR-1049 injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published b...